News
Clinical Trials Arena on MSN1d
First child enrolled in Arcutis’ Phase II trial of cream for atopic dermatitisUS-based biotechnology company Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback